Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | BNT142 |
Trade Name | |
Synonyms | BNT-142|BNT 142 |
Drug Descriptions |
BNT142 consists of an mRNA encoding a bispecific anti-Claudin 6 (CLDN6) and anti-CD3 antibody encapsulated in a lipid nanoparticle, which potentially leads to activation and proliferation of T-lymphocytes and cytotoxic T-lymphocyte mediated cell death of CLDN6-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C187124 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BNT142 | BNT142 | 0 | 1 |